Andreas Laupacis

19.2k total citations · 4 hit papers
115 papers, 12.3k citations indexed

About

Andreas Laupacis is a scholar working on General Health Professions, Economics and Econometrics and Surgery. According to data from OpenAlex, Andreas Laupacis has authored 115 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in General Health Professions, 29 papers in Economics and Econometrics and 18 papers in Surgery. Recurrent topics in Andreas Laupacis's work include Health Systems, Economic Evaluations, Quality of Life (21 papers), Healthcare Policy and Management (11 papers) and Blood transfusion and management (10 papers). Andreas Laupacis is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (21 papers), Healthcare Policy and Management (11 papers) and Blood transfusion and management (10 papers). Andreas Laupacis collaborates with scholars based in Canada, United States and United Kingdom. Andreas Laupacis's co-authors include Dean Fergusson, George A. Wells, Jesse A. Berlin, Drummond Rennie, Howard Mann, Harold C. Sox, David Moher, Douglas G. Altman, Asbjørn Hróbjartsson and Wendy R. Parulekar and has published in prestigious journals such as Nature, The Lancet and JAMA.

In The Last Decade

Andreas Laupacis

113 papers receiving 11.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials

2013 4.4k citations Jennifer Tetzlaff, Douglas G. Altman et al. profile →
The Canadian CT Head Rule for patients with minor head injury

2001 1.0k citations Ian G. Stiell, George A. Wells et al. profile →
A study of the quality of life and cost-utility of renal transplantation

1996 953 citations Andreas Laupacis et al. profile →
Assessing the Quality of Randomized Trials

1999 540 citations George A. Wells, Dean Fergusson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Laupacis Canada	42	2.7k	1.8k	1.8k	1.8k	1.4k	115	12.3k
Mark Helfand United States	35	2.8k 1.0×	2.7k 1.5×	2.0k 1.1×	2.0k 1.1×	647 0.5×	103	15.2k
Cynthia A Beck Canada	25	2.2k 0.8×	1.4k 0.8×	1.6k 0.9×	2.4k 1.3×	481 0.3×	37	11.8k
Carol Coupland United Kingdom	72	3.4k 1.3×	2.6k 1.5×	1.4k 0.8×	2.4k 1.4×	903 0.6×	297	17.9k
Giovanni Apolone Italy	54	2.3k 0.9×	2.1k 1.2×	2.0k 1.1×	2.0k 1.1×	775 0.5×	209	14.9k
Susan D. Horn United States	55	2.4k 0.9×	918 0.5×	2.0k 1.1×	2.1k 1.2×	678 0.5×	243	10.6k
Roman Jaeschke Canada	35	4.4k 1.6×	2.3k 1.3×	1.5k 0.9×	2.9k 1.6×	817 0.6×	68	17.7k
Robert S. Dittus United States	75	3.4k 1.3×	1.4k 0.8×	3.1k 1.7×	2.2k 1.2×	1.8k 1.2×	253	28.5k
Reem A. Mustafa United States	59	2.6k 1.0×	2.0k 1.1×	1.7k 1.0×	2.0k 1.2×	808 0.6×	226	15.7k
Nancy E. Mayo Canada	61	3.0k 1.1×	1.2k 0.6×	1.5k 0.9×	2.4k 1.4×	972 0.7×	373	14.4k
Jill A. Hayden Canada	48	2.4k 0.9×	1.6k 0.9×	1.4k 0.8×	1.8k 1.0×	497 0.3×	153	17.0k

Countries citing papers authored by Andreas Laupacis

Since Specialization

Citations

This map shows the geographic impact of Andreas Laupacis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Laupacis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Laupacis more than expected).

Fields of papers citing papers by Andreas Laupacis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Laupacis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Laupacis. The network helps show where Andreas Laupacis may publish in the future.

Co-authorship network of co-authors of Andreas Laupacis

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Laupacis. A scholar is included among the top collaborators of Andreas Laupacis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Laupacis. Andreas Laupacis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tran, Kim, Fiona Webster, Noah Ivers, Andreas Laupacis, & Irfan A. Dhalla. (2021). Are quality improvement plans perceived to improve the quality of primary care in Ontario?. Canadian Family Physician. 67(10). 759–766. 2 indexed citations

Verma, Amol A., Yishan Guo, Andreas Laupacis, et al.. (2020). Physician-level variation in clinical outcomes and resource use in inpatient general internal medicine: an observational study. BMJ Quality & Safety. 30(2). 123–132. 9 indexed citations

Abdallah, Faraj W., Duminda N. Wijeysundera, Andreas Laupacis, et al.. (2020). Subomohyoid Anterior Suprascapular Block versus Interscalene Block for Arthroscopic Shoulder Surgery. Anesthesiology. 132(4). 839–853. 27 indexed citations

Elliott, Meghan J., Joanna E. M. Sale, Zahra Goodarzi, et al.. (2018). Long‐term views on chronic kidney disease research priorities among stakeholders engaged in a priority‐setting partnership: A qualitative study. Health Expectations. 21(6). 1142–1149. 5 indexed citations

Ahmad, Haroon, Morgan Slater, Babak Aliarzadeh, et al.. (2017). Development of a preliminary essential medicines list for Canada. CMAJ Open. 5(1). E137–E143. 16 indexed citations

Tetzlaff, Jennifer, Douglas G. Altman, Andreas Laupacis, et al.. (2013). Spirit 2013 statement: Defining standard protocol items for clinical trials. Zhongguo xunzheng yixue zazhi. 13(12). 1501–1507. 4 indexed citations

Laupacis, Andreas, et al.. (2012). Systematic review and evaluation of web-accessible tools for management of diabetes and related cardiovascular risk factors by patients and healthcare providers. Journal of the American Medical Informatics Association. 19(4). 514–522. 47 indexed citations

Born, Karen & Andreas Laupacis. (2012). Public Engagement in Ontario's Hospitals – Opportunities and Challenges. Healthcare Quarterly. 15(sp). 16–20. 7 indexed citations

Coburn, Natalie G., Raymond Przybysz, Lisa Barbera, et al.. (2011). Evaluation of CT and MRI scanning among cancer patientsin Ontario. Clinical Imaging. 35(4). 301–308. 4 indexed citations

10.

Chafe, Roger, Andreas Laupacis, & Wendy Levinson. (2011). Accepting new patients. Canadian Family Physician. 57(2). 3 indexed citations

11.

Chafe, Roger, Andreas Laupacis, & Wendy Levinson. (2011). Accepting new patients: What does the public think about Ontario's policy?. PubMed. 57(2). e68–73. 8 indexed citations

12.

You, John J., et al.. (2008). Indications for and results of outpatient computed tomography and magnetic resonance imaging in Ontario.. PubMed. 59(3). 135–43. 25 indexed citations

13.

Shah, Baiju R., Janet E. Hux, Andreas Laupacis, Bernard Zinman, & Merrick Zwarenstein. (2007). Deficiencies in the Quality of Diabetes Care. Journal of General Internal Medicine. 22(2). 275–279. 29 indexed citations

14.

Scales, Damon C. & Andreas Laupacis. (2007). Health technology assessment in critical care. Intensive Care Medicine. 33(12). 2183–2191. 10 indexed citations

15.

Graham, Ian D., Gonzalo G. Alvarez, Jacqueline Tetroe, Laura McAuley, & Andreas Laupacis. (2002). Factors influencing the adoption of blood alternatives to minimize allogeneic transfusion: the perspective of eight Ontario hospitals.. PubMed. 45(2). 132–40. 27 indexed citations

16.

Laupacis, Andreas. (2002). Inclusion of drugs in provincial drug benefit programs: who is making these decisions, and are they the right ones?. PubMed. 166(1). 44–7. 58 indexed citations

17.

Gaitini, Luis, et al.. (2001). The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.. PubMed. 3(11). 809–12. 5 indexed citations

18.

Laupacis, Andreas & Dean Fergusson. (1997). Drugs to Minimize Perioperative Blood Loss in Cardiac Surgery. Anesthesia & Analgesia. 85(6). 1258–1267. 221 indexed citations

19.

Stiell, Ian G., George A. Wells, Katherine L. Vandemheen, et al.. (1997). Variation in ED Use of Computed Tomography for Patients With Minor Head Injury. Annals of Emergency Medicine. 30(1). 14–22. 106 indexed citations

20.

Bloembergen, Wendy E. & Andreas Laupacis. (1991). The Potential of Biotechnology to Improve the Quality of Life of Patients with Renal Failure. Drug Safety. 6(1). 1–7. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact